The news du jour today was SRPT and I want to focus today’s note entirely on it because there is a lot to talk about. In addition, I want to.
We still seem to be in a period of low news flow in terms of biotech stocks, which is fine as it gives me a chance to catch up on.
Really seemed like a quiet summer day to end the week. Not much to talk about but a couple of follow up notes from earlier discussions. 1. To continue from.
Well, we finally had a biotech merger but not any of the ones we expected. Outside of the small cap buyout, there was not a lot new today. 1. SPPI.
Well, there was not a lot of news out there in biotech land but oddly there is a lot I want to talk about and will work through it over.
Got some interesting news today, which makes this a little more exciting but still not a huge news day (the theme for the week). There will not by a note.
Perhaps we were spoiled last week with the ONXX news but this week seems to be getting off to a slow start. There were some decent sized moves in biotech.
Today was the fallout of the AMGN bid for ONXX. There are a couple of aspects of it that I want to touch on and go a little further than.
I thought today would be a much better day in the market for biotechs and they looked strong early but did not seem to have any real follow through. Not.
It was an odd day in the market as it was strong but many biotechs appeared weak. I am going to focus exclusively today on SGEN as we got more.